Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy

Sorensen, A., Mairs, R.J. , Braidwood, L., Joyce, C., Conner, J., Pimlott, S. , Brown, S.M. and Boyd, M. (2012) Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy. Mutagenesis, 27(1), pp. 134-135. (doi: 10.1093/mutage/ger068)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1093/mutage/ger068


Item Type:Articles
Additional Information:Abstracts of the 34th Annual Meeting of the United Kingdom Environmental Mutagen Society, 29th June - 1st July 2011. Held jointly with the Association for Radiation Research at the University of Nottingham, UK
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Pimlott, Dr Sally and Mairs, Professor Robert and Sorensen, Dr Annette
Authors: Sorensen, A., Mairs, R.J., Braidwood, L., Joyce, C., Conner, J., Pimlott, S., Brown, S.M., and Boyd, M.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
College of Medical Veterinary and Life Sciences
Journal Name:Mutagenesis
ISSN:0267-8357
ISSN (Online):1464-3804
Published Online:01 January 2012

University Staff: Request a correction | Enlighten Editors: Update this record